NEW YORK, NY / ACCESS Newswire / August 14, 2025 / If you suffered a loss on your Sable Offshore Corp. (NYSE:SOC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/sable-offshore-corp-lawsuit-submission-form?prid=161574&wire=1&utm_campaign=6 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or […]

NEW YORK, NY / ACCESS Newswire / August 14, 2025 / If you suffered a loss on your Flywire Corporation (NASDAQ:FLYW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/flywire-corporation-lawsuit-submission-form?prid=161575&wire=1&utm_campaign=16 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

NEW YORK, NY / ACCESS Newswire / August 14, 2025 / If you suffered a loss on your Neogen Corporation (NASDAQ:NEOG) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/neogen-corporation-lawsuit-submission-form?prid=161576&wire=1&utm_campaign=27 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

NEW YORK, NY / ACCESS Newswire / August 14, 2025 / If you suffered a loss on your Hims & Hers Health, Inc. (NYSE:HIMS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/hims-hers-health-inc-lawsuit-submission-form?prid=161577&wire=1&utm_campaign=9 or contact Joseph E. Levi, Esq. via email at

(PinkSheets:PPCB),(Pinksheets:PPCB),(NASDAQ:PPCB), MELBOURNE, Australia, Aug. 14, 2025 (GLOBE NEWSWIRE) — Propanc Biopharma, Inc. (OTC Pink: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel cancer treatments for patients suffering from recurring and metastatic cancer, today announced the pricing of an underwritten public offering of 1,000,000 shares of its common stock, par value $0.001 per share,

Sangfor's customer-first innovation and unified SASE architecture deliver real-world impact across APAC. Frost & Sullivanis pleased to announce that Sangforhas been awarded the 2025 APAC Company of the Year Recognition in the secure access service edge (SASE) industry for its outstanding achievements in innovation, customer impact, and strategic market execution. This recognition highlights Sangfor's consistent

Propanc Biopharma Announces Nasdaq Uplisting and Pricing of $4 Million Public Offering Propanc common stock expected to begin trading on Nasdaq under the symbol PPCB GlobeNewswire August 15, 2025 MELBOURNE, Australia, Aug. 14, 2025 (GLOBE NEWSWIRE) — Propanc Biopharma, Inc. (OTC Pink: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel cancer treatments for

NEW YORK CITY, NY AND NEW ORLEANS, LA / ACCESS Newswire / August 14, 2025 / Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until August 25, 2025 to file lead plaintiff applications in securities class action lawsuits against Hims

NEW YORK CITY, NY AND NEW ORLEANS, LA / ACCESS Newswire / August 14, 2025 / Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until September 23, 2025 to file lead plaintiff applications in a securities class action lawsuit against

NEW YORK CITY, NY AND NEW ORLEANS, LA / ACCESS Newswire / August 14, 2025 / Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until September 26, 2025 to file lead plaintiff applications in a securities class action lawsuit against